According to
GuruFocus Insider Data
, the largest CFO sells during the past week were: Visa Inc.,
SciClone Pharmaceuticals Inc., Validus Holding Ltd. and Amsurg
Corp.
Visa Inc. (
V
): CFO Byron H. Pollitt Jr. Sold 85,000 Shares
CFO
Byron H. Pollitt Jr.
sold 85,000 shares of V stock on 06/15/2012 at the average price
of $118. Byron H. Pollitt Jr. owns at least 71,473 shares after
this. The price of the stock has increased by 5.01% since.
Visa operates the world's largest retail electronic payments
network and is one of the most recognized global financial
services brands. Visa Inc. has a market cap of $101.71 billion;
its shares were traded at around $123.91 with a P/E ratio of
22.23 and P/S ratio of 11.07. The dividend yield of Visa Inc
stocks is 0.7%.
For its second quarter of 2012, Visa Inc. reported net income of
$1.1 billion - a increase of 23% over the same quarter last year.
EPS for class A common stock were $1.60, a 30% increase over
prior year quarter. GAAP net operating revenue for the second
quarter was $2.6 billion, which represents growth of 15% year
over year.
Chairman and CEO
Joseph W. Saunders
sold 12,420 shares of V stock on 06/21/2012 at the average price
of $120.76.
SciClone Pharmaceuticals Inc. (
SCLN
): Senior Vice President Finance and CFO Gary Titus Sold 81,607
Shares
Senior Vice President Finance and CFO
Gary Titus
sold 81,607 shares of SCLN stock on 06/15/2012 at the average
price of $7. Gary Titus owns at least 37,095 shares after this.
The price of the stock has decreased by 1.14% since.
SciClone Pharmaceuticals Inc. develops and commercializes novel
medicines for treating a broad range of the world's most serious
diseases. SciClone Pharmaceuticals Inc. has a market cap of
$393.03 million; its shares were traded at around $6.92 with a
P/E ratio of 11.53 and P/S ratio of 2.94.
SciClone Pharmaceuticals has released its first quarter 2012
results ended March 31, 2012. During this quarter, SciClone
reported revenue increase of 81% year over year to $39.2 million.
GAAP net income for the company was $8.7 million ($0.15 per
share), compared to $3.8 million ($0.08) prior year quarter.
Validus Holdings Ltd. (
VR
): President and CFO Joseph E. Consolino Sold 59,866
Shares
President and CFO Joseph E. Consolino sold 59,866 shares of VR
stock on 06/19/2012 at the average price of $31.12. Joseph E.
Consolino owns at least 264,756 shares after this. The price of
the stock has increased by 0.64% since.
Validus Holdings Ltd. has a market cap of $3.11 billion; its
shares were traded at around $31.32 with a P/E ratio of 11.27 and
P/S ratio of 1.62. The dividend yield of Validus Holdings Ltd.
stocks is 3.19%.
For its first quarter ended March 31, 2012, Validus Holdings
reported net income of $124.2 million ($1.18 per share), compared
to a net loss of $172.4 million ($1.78) in the first quarter of
2011.
Executive Vice President and Chief Risk Officer Stuart W. Mercer,
Alok Singh, and multiple other insiders also recently sold shares
of VR stock.
Amsurg Corp (
AMSG
): Executive Vice President and CFO Claire M. Gulmi Sold 58,145
Shares
Executive VP & CFO Claire M. Gulmi sold 58,145 shares of AMSG
stock on 06/15/2012 at the average price of $29.07. Claire M.
Gulmi owns at least 96,165 shares after this. The price of the
stock has increased by 1.17% since.
AmSurg Corp. is in the business of developing, acquiring and
operating practice-based ambulatory surgery centers, in
partnerships with physician practice groups, throughout the
United States. AmSurg Corp. has a market cap of $930.41 million;
its shares were traded at around $29.41 with a P/E ratio of 16.07
and P/S ratio of 1.18. AmSurg Corp. had an annual average
earnings growth of 10.8% over the past 10 years. GuruFocus rated
AmSurg Corp. the business predictability rank of 3.5-star.
For the complete list of stocks that Sold by their CFOs, go to:
Insider Buys.About GuruFocus: GuruFocus.com tracks the stocks
picks and portfolio holdings of the world's best investors. This
value investing site offers stock screeners and valuation tools.
And publishes daily articles tracking the latest moves of the
world's best investors. GuruFocus also provides promising stock
ideas in 3 monthly newsletters sent to
Premium Members
.